Joe Su

Dr. Joe Su

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
BCBrianna Cote
Brianna Cote
Fawzy ElbarbryFawzy Elbarbry
Fawzy Elbarbry
FBFiona Q Bui
Fiona Q Bui
JSJoe Su
Joe Su
KSKaren Seo
Karen Seo
DRDeepa A. Rao
Deepa A. Rao
Chronic inflammatory diseases occur in a large portion of the population and are associated with a poor diet. Key natural products found in fruits and vegetables may assist in lowering inflammation associated with chronic diseases such as obesity, diabetes, cardiovascular diseases, and cancer. This review seeks to examine the roles of several natural products, resveratrol (RES), quercetin (QUE), curcumin (CUR), piperine (PIP), epigallocatechin gallate (EGCG), and gingerol (GIN), in their ability to attenuate inflammatory markers in specific diseases states. Additionally, we will discuss findings in past and ongoing clinical trials, detail possible phytochemical–drug interactions, and provide a brief resource for researchers and healthcare professionals on natural product and supplement regulation as well as names of databases with information on efficacy, indications, and natural product–drug interactions. As diet and over-the-counter supplement use are modifiable factors and patients are interested in using complementary and alternative therapies, understanding the mechanisms by which natural products have demonstrated efficacy and the types of drugs they interact with and knowing where to find information on herbs and supplements is important for practicing healthcare providers and researchers interested in this field.


15 January 2007 in Acta crystallographica Section B, Structural science, crystal engineering and materials
Verified
Journal Article
Closed access
PDF file
IGIlia A. Guzei
Ilia A. Guzei
LSLara C. Spencer
Lara C. Spencer
JSJoe Su
Joe Su
RBRonald R. Burnette
Ronald R. Burnette

19 January 2018 in INNOVATIONS in pharmacy
Verified
Journal Article
Open access
RKReza Karimi
Reza Karimi
JFJeff Fortner
Jeff Fortner
DRDeepa Rao
Deepa Rao
JSJoe Su
Joe Su
Objective: To promote first year (P1) pharmacy students’ awareness of medication error prevention and to support student learning in biomedical and pharmaceutical sciences. Innovation: A novel curricular activity was created and referred to as “Medication Errors and Sciences Applications (MESA)”. The MESA activity encouraged discussions of patient safety among students and faculty to link medication errors to biomedical and pharmaceutical sciences, which ultimately reinforced student learning in P1 curricular topics. Critical Analysis: Three P1 cohorts implemented the MESA activity and approximately 75% of students from each cohort completed a reliable assessment instrument. Each P1 cohort had at least 14 student teams who generated professional reports analyzing authentic medication errors. The quantitative assessment results indicated that 70-85% of students believed that the MESA activity improved student learning in biomedical and pharmaceutical sciences. More than 95% of students agreed that the MESA activity introduced them to medication errors. Approximately 90% of students agreed that the MESA activity integrated the knowledge and skills they developed through the P1 curriculum, promoted active learning and critical thinking, and encouraged students to be self-directed learners. Furthermore, our data indicated that approximately 90% of students stated that the achievement of Bloom’s taxonomy's six learning objectives was promoted by completing the MESA activity. Next Steps: Pharmacy students’ awareness of medication errors is a critical component of pharmacy education, which pharmacy educators can integrate with biomedical and pharmaceutical sciences to enhance student learning in the P1 year. Treatment of Human Subjects: IRB exemption granted Type: Note

17 October 2009 in Acta Crystallographica Section E Structure Reports Online
Verified
Journal Article
Open access
PDF file
IGIlia A. Guzei
Ilia A. Guzei
JSJoe Su
Joe Su
LSLara C. Spencer
Lara C. Spencer
RBRonald R. Burnette
Ronald R. Burnette
The title compound, [Na(C(18)H(36)N(2)O(6))]ClO(4), was isolated and crystallized to understand more fully the ligand's binding specificity to cations. The cation and anion reside at an inter-section of crystallographic twofold and threefold axes. The carbon atoms in the cation are disordered over two positions in a 3:2 ratio, and the anion is equally disordered over two positions. The geometries of the cation and anion are typical. The compound packs in alternating sheets of discrete cations and anions stacked along the c axis, separated by a distance equal to one-sixth the length of the c axis.